Home » Stocks » BTCY

Biotricity Inc. (BTCY)

Stock Price: $2.40 USD 0.18 (7.87%)
Updated May 5, 2021 3:59 PM EDT - Market closed
Market Cap 85.04M
Revenue (ttm) 1.96M
Net Income (ttm) -15.50M
Shares Out 35.59M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 5
Last Price $2.40
Previous Close $2.23
Change ($) 0.18
Change (%) 7.87%
Day's Open 2.25
Day's Range 2.24 - 2.59
Day's Volume 179,331
52-Week Range 0.67 - 3.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that ...

4 days ago - Accesswire

Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consum...

3 weeks ago - Accesswire

AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (“the Compa...

1 month ago - GlobeNewsWire

REDWOOD CITY, CA / ACCESSWIRE / March 15, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce th...

1 month ago - Accesswire

REDWOOD CITY, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) --  Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss the highli...

3 months ago - GlobeNewsWire

REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series of c...

3 months ago - GlobeNewsWire

About BTCY

Biotricity, Inc., medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry technology, an integrated electrocardiogram (ECG) device and software solution. Biotricity, Inc. has a research partnership with the University of Calgary to determine the predictive value of ECG r... [Read more...]

Industry
Medical Devices
Stock Exchange
OTCMKTS
Ticker Symbol
BTCY
Full Company Profile

Financial Performance

In 2019, Biotricity's revenue was $1.42 million, an increase of 256.03% compared to the previous year's $398,200. Losses were -$11.07 million, 28.8% more than in 2018.

Financial Statements